U.S. Markets open in 1 hr, 39 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,451.19 | -128.00 | -1.49% |
| NASDAQ | 1,649.51 | 4.39 | 0.27% |
| S&P 500 | 899.22 | -10.70 | -1.18% |
| Day Low 01:49 PM EDT | 7.62 | |
|---|---|---|
| Day High 03:37 PM EDT | 8.79 |
|
| Range | 1.17 | |
| Volume | 582,875 | |
| 30-Day Avg. Vol. | 388,000 |
|
| Difference | 50.23% | |
| Market Cap. | 457.16 M | |
| Change | 22.41 M | |
| Shares Out. | 61.52 M | |
| Percent Traded | 1.12% | |
| Revenue (LFY) | 22 M | |
| Earnings (TTM) | -159.99 M | |
| Next Earnings | 10/23/2008 |
|
| EPS (TTM) | -2.00 |
| 52-Wk Low 10/10/08 | 7.62 | |
|---|---|---|
| 52-Wk High 10/10/07 | 27.93 |
|
| Range | 20.31 | |
| Prev. Close 10/9/08 | 8.34 | |
| Today's Open | 8.21 | |
| Change | -1.56% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.5954 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -6.00 |
Theravance figures there's no sense in re-inventing the wheel. The biotechnology firm takes aim at already proven biological targets, taking advantage of previous years of research to create more effective, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.48 3/31/08 | -0.49 3/31/08 |
-0.01
Missed
|
| Last Quarter | -0.486 6/30/08 | -0.44 6/30/08 |
0.046
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 5.50 M | 22.00 M |
| Gross Profit | 3.19 M | 17.94 M |
| Operating Income | -21.75 M | -168.56 M |
| Net Income | -27.03 M | -160.00 M |
